- Home
- OVID vs PLCE Comparison
OVID vs PLCE Comparison
Compare OVID & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OVID | PLCE |
|---|---|---|
| Founded | 2014 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.5M | 100.2M |
| IPO Year | 2017 | 1997 |
Fundamental Metrics
Financial Performance| Metric | OVID | PLCE |
|---|---|---|
| Price | $1.60 | $4.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $3.40 | ★ $4.50 |
| AVG Volume (30 Days) | ★ 1.7M | 299.4K |
| Earning Date | 03-10-2026 | 12-16-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,610,000.00 | ★ $1,288,160,000.00 |
| Revenue This Year | $1,077.56 | N/A |
| Revenue Next Year | N/A | $1.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 945.89 | N/A |
| 52 Week Low | $0.24 | $3.66 |
| 52 Week High | $2.01 | $11.99 |
Technical Indicators
Market Signals| Indicator | OVID | PLCE |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 34.97 |
| Support Level | $1.40 | $3.84 |
| Resistance Level | $1.61 | $4.22 |
| Average True Range (ATR) | 0.12 | 0.21 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 15.91 | 20.00 |
Price Performance
Historical ComparisonAbout OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.